Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital and industry converge at Campus Grand Parc.
The acquisition is expected to close in the second half of 2026, pending customary closing conditions and regulatory approvals.
Financial research published in the BMJ shows the trade deal could end up costing the NHS tens of billions.
Roche’s breast cancer agreement with Astex is one of several oncology deals the Swiss pharma giant has inked in recent years.
The health agency is conducting a trial on the first potentially effective treatments for Bundibugyo virus, while adding the first diagnostic test to its emergency use list.
The transaction will see UniD Manufacturing rebranded as Besins Healthcare PharmTech.
